Accelerator-free nitrile gloves: what buyers should verify

Glove-related skin symptoms can have different causes, and a product label cannot diagnose them. HSE distinguishes immediate type I allergy to natural rubber latex proteins, delayed type IV allergy to chemical additives used in rubber manufacture, and irritant contact dermatitis. Irritation can be associated with wet work, soaps, cleaning chemicals, sweating, occlusion or incorrect glove use rather than an allergy.

The distinction matters because the control can differ. Changing from latex to nitrile removes natural rubber latex exposure, but it does not prove that the new glove avoids an accelerator relevant to a diagnosed type IV allergy. Likewise, changing formulation will not remove every source of irritation in a work process.

• Type I natural-rubber-latex allergy is an immediate response to latex proteins.
• Type IV allergic contact dermatitis is a delayed response to a specific sensitising chemical, which can include rubber accelerators.
• Irritant contact dermatitis is not an allergic response and can have several workplace causes.
• Clinical assessment may be needed because visible symptoms can be difficult to distinguish.

Nitrile gloves are made from synthetic rubber rather than natural rubber latex. That supports a latex-free material claim when it is accurate for the exact product, but rubber accelerator chemicals can also be used when manufacturing synthetic rubber products. The British Society for Cutaneous Allergy notes that relevant accelerators may be found in both latex and nitrile items.

Procurement records should therefore keep two separate fields: natural-rubber-latex status and accelerator formulation status. Do not treat a material name, colour, powder-free statement or generic product-family description as evidence for both.

There is no useful procurement decision in an undefined claim. Ask the manufacturer or supplier for a current written statement that identifies the exact product reference, formulation scope and accelerator groups addressed. If the wording says free from selected accelerators, record the selected list rather than shortening it to accelerator-free internally.

The evidence pack should also explain how the claim is controlled. Relevant questions include whether it is based on the formulation, supplier declarations, analytical testing or a combination, what detection or reporting limits apply where testing is cited, and how changes in raw materials or production trigger review.

• Exact glove name, product reference, sizes and colours within scope.
• The specific accelerator chemicals or groups covered by the statement.
• Statement owner, issue date, revision and supporting method.
• Factory, formulation and raw-material change-control process.
• Route for investigating a wearer concern or contradictory result.

Accelerator-free describes one aspect of composition. It does not establish an intended medical purpose, PPE category, chemical resistance, microbiological protection, food-contact status, durability or fit. Those questions still need current evidence for the exact SKU, intended use and destination market.

For chemical tasks, HSE advises selecting from the substance, type and duration of contact, wearer and workplace conditions. Review product-specific permeation and degradation information for the chemical, concentration and temperature involved. A formulation change made to avoid an accelerator should not be assumed to preserve the results of another glove.

• Confirm the stated intended use and applicable regulatory route.
• Match declarations, certificates and test reports to the exact reference.
• Check thickness, length, size range, grip and expected wear conditions.
• Review chemical data for the actual substance and contact scenario where relevant.
• Verify current food-contact documentation and restrictions for food tasks.

A purchasing change should not require a worker to diagnose their own symptoms or repeatedly trial products without support. HSE says employers should assess dermatitis risks and use suitable health surveillance where appropriate. The level of surveillance depends on the hazard, exposure, activities, glove type and workplace history.

Involve occupational health or another competent professional when a worker has symptoms or a known allergy. A controlled wearer evaluation can then assess fit, comfort, dexterity and task performance without presenting the trial as a medical test. Record feedback by exact product reference and lot so concerns can be investigated.

Once an exact glove is approved, lock the formulation statement, product specification, evidence set and packaging reference into the purchasing record. Substitution by a similar name or colour can undermine the reason for the change.

Require notification before a change to formulation, raw-material source, manufacturing site, product reference or claim wording. Reassess the affected evidence and wearer controls before accepting the changed product into routine supply.

Use this checklist to turn a broad marketing phrase into a reviewable procurement decision.

• Has occupational health or a competent professional defined the workplace need where symptoms are involved?
• Are latex-free and accelerator-free recorded as separate claims?
• Does a current written statement identify the exact SKU, sizes and colours?
• Does the supplier define which accelerator chemicals or groups the claim covers?
• Is the supporting method and change-control route clear?
• Do intended use, regulatory status and task-specific performance evidence still fit the requirement?
• Have fit, comfort, donning, grip and glove-change procedures been evaluated?
• Can purchasing prevent unapproved substitution and trace concerns to a lot?